WaveMan
WaveMan · Form 4
Megna Michael R insider trades
> Search tickers & screens ⌘K
LIVE

Megna Michael R insider trades

Megna Michael R has filed 35 Form 4s with the SEC that we hold, all for Kiniksa Pharmaceuticals International, plc (KNSA), as CHIEF ACCOUNTING OFFICER. Across all of them we count 0 purchases worth $0 and 15 sales worth $5.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($678.7K). The largest single trade was a sale of 37,255 shares of Kiniksa Pharmaceuticals International, plc worth $1.4M, dated 2025-10-20. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-07 and the latest 2026-09-03.

Kiniksa Pharmaceuticals International, plc (KNSA)

CHIEF ACCOUNTING OFFICER · 35 filings · 15 purchases and sales
Trade dateCodeSharesValue as filedFiledSource
2023-12-19S, sale reported on Form 49,316$178.2K2023-12-21SEC
2024-01-02S, sale reported on Form 416,670$319.6K2024-01-04SEC
2024-02-28S, sale reported on Form 45,126$111.7K2024-03-01SEC
2024-03-01S, sale reported on Form 49,659$207.2K2024-03-01SEC
2024-11-27S, sale reported on Form 48,637$193.9K2024-12-02SEC
2024-11-29S, sale reported on Form 49$2022024-12-02SEC
2025-03-12S, sale reported on Form 49,051$203.2K2025-03-14SEC
2025-05-07S, sale reported on Form 417,647$471.0K2025-05-09SEC
2025-06-03S, sale reported on Form 415,211$437.3K2025-06-05SEC
2025-08-04S, sale reported on Form 417,000$550.0K2025-08-06SEC
2025-09-03S, sale reported on Form 411,000$383.2K2025-09-03SEC
2025-10-20S, sale reported on Form 437,255$1.4M2025-10-22SEC
2025-10-20S, sale reported on Form 413,235$520.3K2025-10-22SEC
2026-04-09S, sale reported on Form 46,625$309.3K2026-04-13SEC
2026-09-03S, sale reported on Form 44,600$369.4K2026-09-03SEC
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1464583) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms